Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1

• Published in: Cancer cell Vol. 20; no. 4; pp. 457 - 471
• Main Authors: Cai, Changmeng, He, Housheng Hansen, Chen, Sen, Coleman, Ilsa, Wang, Hongyun, Fang, Zi, Chen, Shaoyong, Nelson, Peter S., Liu, X. Shirley, Brown, Myles, Balk, Steven P.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 18.10.2011
• Subjects: Androgens - pharmacology; Cell Line, Tumor; Enhancer Elements, Genetic; Gene Expression Regulation, Neoplastic; Histone Demethylases - metabolism; Histones - metabolism; Humans; Male; Methylation; Prostatic Neoplasms - enzymology; Prostatic Neoplasms - genetics; Prostatic Neoplasms - metabolism; Receptors, Androgen - genetics; RNA, Messenger - metabolism
• ISSN: 1535-6108; 1878-3686
• DOI: 10.1016/j.ccr.2011.09.001

Androgen receptor (AR) is reactivated in castration-resistant prostate cancer (CRPC) through mechanisms including marked increases in AR gene expression. We identify an enhancer in the AR second intron contributing to increased AR expression at low androgen levels in CRPC. Moreover, at increased androgen levels, the AR binds this site and represses AR gene expression through recruitment of lysine-specific demethylase 1 (LSD1) and H3K4me1,2 demethylation. AR similarly represses expression of multiple genes mediating androgen synthesis, DNA synthesis, and proliferation while stimulating genes mediating lipid and protein biosynthesis. Androgen levels in CRPC appear adequate to stimulate AR activity on enhancer elements, but not suppressor elements, resulting in increased expression of AR and AR repressed genes that contribute to cellular proliferation. ► AR gene expression in CRPC is increased by an enhancer in the second intron ► This enhancer is repressed by AR at high androgen levels through LSD1 recruitment ► AR represses genes mediating androgen synthesis, DNA synthesis, and cell cycling ► Decreased androgen in CRPC relieves repression but supports AR-dependent growth